INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 204 filers reported holding INSMED INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,780,784 | +9.3% | 149,734 | -8.6% | 0.01% | +20.0% |
| Q2 2023 | $3,458,269 | +19.8% | 163,899 | -3.2% | 0.01% | +25.0% |
| Q1 2023 | $2,886,736 | -15.2% | 169,310 | -0.6% | 0.00% | -20.0% |
| Q4 2022 | $3,402,994 | +5.4% | 170,320 | +13.6% | 0.01% | 0.0% |
| Q3 2022 | $3,229,000 | +7.5% | 149,929 | -1.6% | 0.01% | 0.0% |
| Q2 2022 | $3,005,000 | -16.0% | 152,405 | +0.1% | 0.01% | 0.0% |
| Q1 2022 | $3,579,000 | -18.6% | 152,296 | -5.7% | 0.01% | 0.0% |
| Q4 2021 | $4,398,000 | +3.0% | 161,468 | +4.2% | 0.01% | 0.0% |
| Q3 2021 | $4,269,000 | +5.4% | 155,005 | +8.9% | 0.01% | 0.0% |
| Q2 2021 | $4,050,000 | -22.1% | 142,312 | -6.8% | 0.01% | -28.6% |
| Q1 2021 | $5,200,000 | +1.9% | 152,668 | -0.4% | 0.01% | 0.0% |
| Q4 2020 | $5,102,000 | +3.6% | 153,270 | +0.0% | 0.01% | -12.5% |
| Q3 2020 | $4,926,000 | +17.2% | 153,263 | +0.4% | 0.01% | +14.3% |
| Q2 2020 | $4,204,000 | +93.8% | 152,649 | +12.8% | 0.01% | +40.0% |
| Q1 2020 | $2,169,000 | -33.2% | 135,338 | -0.5% | 0.01% | -16.7% |
| Q4 2019 | $3,248,000 | +32.7% | 136,009 | -2.0% | 0.01% | +20.0% |
| Q3 2019 | $2,448,000 | -19.9% | 138,756 | +16.2% | 0.01% | -16.7% |
| Q2 2019 | $3,056,000 | -10.4% | 119,361 | +1.8% | 0.01% | -14.3% |
| Q1 2019 | $3,409,000 | +116.6% | 117,253 | -2.2% | 0.01% | +75.0% |
| Q4 2018 | $1,574,000 | -33.6% | 119,943 | +2.4% | 0.00% | -20.0% |
| Q3 2018 | $2,369,000 | -14.5% | 117,158 | -0.0% | 0.01% | -16.7% |
| Q2 2018 | $2,772,000 | +5.6% | 117,199 | +0.6% | 0.01% | 0.0% |
| Q1 2018 | $2,624,000 | -30.2% | 116,525 | -3.4% | 0.01% | -25.0% |
| Q4 2017 | $3,761,000 | +1.3% | 120,610 | +1.4% | 0.01% | 0.0% |
| Q3 2017 | $3,712,000 | +96.8% | 118,925 | +8.2% | 0.01% | +100.0% |
| Q2 2017 | $1,886,000 | -11.7% | 109,920 | -9.9% | 0.00% | 0.0% |
| Q1 2017 | $2,135,000 | +26.6% | 121,948 | -4.4% | 0.00% | +33.3% |
| Q4 2016 | $1,687,000 | -11.4% | 127,548 | -2.7% | 0.00% | -25.0% |
| Q3 2016 | $1,903,000 | +48.7% | 131,048 | +0.9% | 0.00% | +33.3% |
| Q2 2016 | $1,280,000 | -22.5% | 129,848 | -0.4% | 0.00% | -25.0% |
| Q1 2016 | $1,651,000 | -20.2% | 130,313 | +14.4% | 0.00% | -20.0% |
| Q4 2015 | $2,068,000 | -0.7% | 113,929 | +1.6% | 0.01% | 0.0% |
| Q3 2015 | $2,082,000 | -24.1% | 112,125 | -0.2% | 0.01% | -28.6% |
| Q2 2015 | $2,743,000 | +46.0% | 112,325 | +24.4% | 0.01% | +75.0% |
| Q1 2015 | $1,879,000 | +32.1% | 90,329 | -1.7% | 0.00% | +33.3% |
| Q4 2014 | $1,422,000 | +19.0% | 91,929 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $1,195,000 | -16.6% | 91,538 | +27.6% | 0.00% | -25.0% |
| Q2 2014 | $1,433,000 | +20.2% | 71,726 | +14.5% | 0.00% | +33.3% |
| Q1 2014 | $1,192,000 | +11.9% | 62,626 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,065,000 | +10.1% | 62,626 | +1.1% | 0.00% | 0.0% |
| Q3 2013 | $967,000 | +64.2% | 61,926 | +25.8% | 0.00% | +50.0% |
| Q2 2013 | $589,000 | – | 49,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |